Mangoceuticals, Inc. (MGRX)

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $5.81 million. The enterprise value is $4.89 million.

Market Cap	5.81M
Enterprise Value	4.89M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 16.97 million shares outstanding. The number of shares has increased by 408.93% in one year.

Current Share Class	16.97M
Shares Outstanding	16.97M
Shares Change (YoY)	+408.93%
Shares Change (QoQ)	+23.12%
Owned by Insiders (%)	16.34%
Owned by Institutions (%)	5.90%
Float	10.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.30
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	6.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.02.

Current Ratio	1.74
Quick Ratio	1.67
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-169.97

Financial Efficiency

Return on equity (ROE) is -141.66% and return on invested capital (ROIC) is -74.13%.

Return on Equity (ROE)	-141.66%
Return on Assets (ROA)	-69.91%
Return on Invested Capital (ROIC)	-74.13%
Return on Capital Employed (ROCE)	-115.76%
Weighted Average Cost of Capital (WACC)	18.65%
Revenue Per Employee	$152,007
Profits Per Employee	-$7.27M
Employee Count	3
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.58% in the last 52 weeks. The beta is 2.55, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y)	2.55
52-Week Price Change	-78.58%
50-Day Moving Average	0.39
200-Day Moving Average	1.32
Relative Strength Index (RSI)	46.18
Average Volume (20 Days)	17,543,869

Short Selling Information

The latest short interest is 1.22 million, so 7.20% of the outstanding shares have been sold short.

Short Interest	1.22M
Short Previous Month	1.74M
Short % of Shares Out	7.20%
Short % of Float	12.09%
Short Ratio (days to cover)	0.06

Income Statement

In the last 12 months, Mangoceuticals had revenue of $456,021 and -$21.82 million in losses. Loss per share was -$2.17.

Revenue	456,021
Gross Profit	250,386
Operating Income	-17.59M
Pretax Income	-20.64M
Net Income	-21.82M
EBITDA	-15.87M
EBIT	-17.59M
Loss Per Share	-$2.17

Balance Sheet

The company has $1.49 million in cash and $307,823 in debt, with a net cash position of $1.18 million or $0.07 per share.

Cash & Cash Equivalents	1.49M
Total Debt	307,823
Net Cash	1.18M
Net Cash Per Share	$0.07
Equity (Book Value)	15.20M
Book Value Per Share	0.96
Working Capital	656,866

Cash Flow

Operating Cash Flow	-5.85M
Capital Expenditures	n/a
Depreciation & Amortization	1.72M
Net Borrowing	468,500
Free Cash Flow	-5.85M
FCF Per Share	-$0.34

Margins

Gross Margin	54.91%
Operating Margin	-3,858.11%
Pretax Margin	-4,526.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-408.93%
Shareholder Yield	-408.93%
Earnings Yield	-359.70%
FCF Yield	-96.45%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Mangoceuticals has an Altman Z-Score of 5.38 and a Piotroski F-Score of 1.

Altman Z-Score	5.38
Piotroski F-Score	1